SMi Reports: Pain Therapeutics will return to London for its 20th consecutive year to explore the cutting-edge research of novel therapeutics SMi Group are pleased to announce the 20th annual Pain Therapeutics Conference, taking place in London […]
The US Centers for Disease Control and Prevention (CDC) has reported the first case of 2019 Novel Coronavirus (2019-nCoV) in the US state of Washington following the return of a patient from China who tested […]
Daiichi Sankyo and AstraZeneca said that the HER2 directed antibody drug conjugate (ADC) DS-8201 has met the primary endpoint in the phase 2 DESTINY-Gastric01 trial. DS-8201 is trastuzumab deruxtecan in Japan and other regions of […]
Researchers in China have chosen to test 30 existing medicines, biologically active natural products and the country’s traditional medicines for potential therapeutic effects against the Wuhan coronavirus (2019-nCoV), according to the Chinese Academy of Sciences […]
Calidi Biotherapeutics, a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies for cancer, announced Series A investments from two South Korean firms to advance manufacturing in preparation for Calidi’s pre-IND and IND […]